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BACKGROUND AND PURPOSE
Transient receptor potential canonical 5 (TRPC5) channels are widely expressed, including in the CNS, where they potentiate
fear responses. They also contribute to other non-selective cation channels that are stimulated by G-protein-coupled receptor
agonists and lipid and redox factors. Steroids are known to modulate fear and anxiety states, and we therefore investigated
whether TRPC5 exhibited sensitivity to steroids.
EXPERIMENTAL APPROACH
Human TRPC5 channels were conditionally expressed in HEK293 cells and studied using intracellular Ca2+ measurement,
whole-cell voltage-clamp and excised patch techniques. For comparison, control experiments were performed with cells
lacking TRPC5 channels or expressing another TRP channel, TRPM2. Native TRPC channel activity was recorded from vascular
smooth muscle cells.
KEY RESULTS
Extracellular application of pregnenolone sulphate, pregnanolone sulphate, pregnanolone, progesterone or
dihydrotestosterone inhibited TRPC5 activity within 1–2 min. Dehydroepiandrosterone sulphate or 17b-oestradiol had weak
inhibitory effects. Pregnenolone, and allopregnanolone, a progesterone metabolite and stereo-isomer of pregnanolone, all had
no effects. Progesterone was the most potent of the steroids, especially against TRPC5 channel activity evoked by sphingosine-
1-phosphate. In outside-out patch recordings, bath-applied progesterone and dihydrotestosterone had strong and reversible
effects, suggesting relatively direct mechanisms of action. Progesterone inhibited native TRPC5-containing channel activity,
evoked by oxidized phospholipid.
CONCLUSIONS AND IMPLICATIONS
Our data suggest that TRPC5 channels are susceptible to relatively direct and rapid stereo-selective steroid modulation,
leading to channel inhibition. The study adds to growing appreciation of TRP channels as non-genomic steroid sensors.
Abbreviations
HEK 293 cells, human embryonic kidney cells; LPC, lysophosphatidylcholine; PGPC, 1-palmitoyl-2-glutaroyl-
phosphatidylcholine; S1P, sphingosine-1-phosphate; TRPC, transient receptor potential canonical; TRPM, transient
receptor potential melastatin
Introduction
The seven mammalian transient receptor potential canonical
(TRPC) proteins assemble to form non-selective Ca
2+-
permeable channels (Birnbaumer, 2009; channel and recep-
tor nomenclature follows Alexander et al., 2009). The human
TRPC5 gene was identiﬁed in a region on the X-chromosome
that contains loci for non-syndromic mental retardation
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sion is not restricted to the nervous system, the only known
phenotype of Trpc5 gene-disrupted mice is reduced innate
fear responses to aversive stimuli (Riccio et al., 2009). There-
fore, there is potential for TRPC5 channels to be the target of
substances that promote or suppress anxiety. The channel
activity is already known to be potentiated by acidosis and
the toxic metal ion Pb
2+ (Semtner et al., 2007; Sukumar and
Beech, 2010), effects that may contribute to fear responses of
suffocation and poisoning. However, inhibitors of the chan-
nels with anxiolytic activity are not known.
Neuroactive steroids are synthesized from cholesterol in
the brain, adrenal glands and gonads (Compagnone and
Mellon, 2000). They include pregnenolone sulphate,
pregnenolone, dehydroepiandrosterone, progesterone, preg-
nanolone, allopregnanolone and testosterone (Charala-
mpopoulos et al., 2008; Schumacher et al., 2008; Veleiro and
Burton, 2009). Several of the steroids, including progester-
one and testosterone, are anxiolytic, and have putative roles
in anxiety disorders (Edinger and Frye, 2005). Progesterone
is also a major sex hormone that can reach high serum
concentrations in females. Female rats display reduced
anxiety at pro-oestrus, when progesterone concentrations
are high. Anxiolytic effects are mediated by GABAA receptor
modulation (Toufexis et al., 2004), but may also involve
additional mechanisms (Auger and Forbes-Lorman, 2008).
Such steroids also have other wide-ranging effects that
could potentially be explained, at least partially, by actions
on widely distributed ion channels such as TRPC
channels.
A small number of studies have suggested links between
TRP channels and steroids. Endogenous capsaicin responses,
presumably mediated by TRPV1, a member of the TRP Vanil-
loid (V) channels, are inhibited by pregnenolone sulphate
and dehydroepiandrosterone (Chen and Wu, 2004), and a
member of the melastatin (M) class of TRP channels, TRPM3,
is stimulated by pregnenolone sulphate and dehydroepi-
androsterone sulphate (Wagner et al., 2008; Majeed et al.,
2010). There are no reports of other TRP channels being
linked with neuroactive steroids, although TRPC2 (which is
not expressed in humans) is stimulated by corticosterone
21-sulphate, a component of mouse urine (Nodari et al.,
2008). TRPM3 is not stimulated by corticosterone 21-sulphate
(Majeed et al., 2010). During studies of TRPM3 channels, we
tested pregnenolone sulphate against TRPC5 in a counter
screen and found activity. Here we describe these effects and
report on an investigation of the steroid structure-activity
relationships. Our data suggest that TRPC5 channels should
be added to the list of non-genomic membrane steroid
sensors.
Methods
Cell culture
Human TRPC5 and TRPM2 channels were expressed as
described previously (McHugh et al., 2003; Zeng et al., 2004).
TRP channel cDNA, stably incorporated into HEK293 cells,
was under the control of a tetracycline-inducible promoter,
such that addition of 1 mg·mL
-1 tetracycline (Tet+)-induced
expression of exogenous channels. Cells not treated with
tetracycline (Tet-) were used as control. Cells were maintained
in Dulbecco’s modiﬁed Eagle’s medium-F12 + GLUTAMAX
(Cat No. 31331, Gibco, Paisley, UK) supplemented with 10%
fetal calf serum, 100 units·mL
-1 penicillin/streptomycin
(Sigma, St. Louis, MO, USA) and the selection antibiotics
(10 mg·mL
-1 blasticidin and 400 mg·mL
-1 zeocin; Invitrogen,
Paisley, UK) at 37°C in a 5% CO2 incubator.
Freshly discarded human saphenous vein segments were
obtained anonymously and with informed consent from
patients undergoing open heart surgery in the General Inﬁr-
mary at Leeds. Approval was granted by the Leeds Teaching
Hospitals Local Research Ethics Committee. Proliferating vas-
cular smooth muscle cells (VSMC) were prepared from these
segments using an explant technique and grown in Dulbec-
co’s modiﬁed Eagle’s medium + GLUTAMAX (Cat # 31966,
Gibco). The medium was supplemented with 10% fetal calf
serum, 100 units·mL
-1 penicillin/streptomycin (Sigma) at
37°C in a 5% CO2 incubator. Experiments were performed on
cells passaged 3–5 times.
Ca
2+ measurement
Twenty-four hours prior to intracellular Ca
2+ measurements,
HEK293 cells were plated at 80–90% conﬂuence in clear-
bottom poly-D lysine coated 96-well plates (Corning, NY,
USA) or VSMCs were plated at 80–90% conﬂuence in non-
coated, square-bottomed clear plates (Cat No. 167008,
Nunclon, Roskilde, Denmark). Immediately prior to record-
ings, cells were incubated for 1 h at 37°C in standard bath
solution (SBS) containing 2 mM fura-2 acetoxymethyl ester
(and 0.01% pluronic acid), and then washed with SBS once
before adding the recording buffer (SBS with appropriate
solvent). All experiments were at 23  2°C. SBS in de-ionized
water contained (in mM): NaCl 135, KCl 5, MgCl2 1.2, CaCl2
1.5, glucose 8 and HEPES 10; pH was titrated to 7.4 using
4 M NaOH. The osmolality of this solution was
290 mOsm·kg
-1. Calcium-free SBS was SBS without added
CaCl2. Measurements were made on a 96-well ﬂuorescence
plate reader (FlexStation II
384, Molecular Devices, Sunnyvale,
CA, USA). Fura-2 was excited by light of 340 and 380 nm
and emitted light was collected at 510 nm. Wells of the
96-well plate were studied in a column format and loaded
alternately for test and control conditions. Intracellular
calcium (Ca
2+
i) concentration is indicated as the ratio of
fura-2 ﬂuorescence (F) emission intensities for 340 and
380 nm (F ratio).
Electrophysiology
Recordings were made using the whole-cell or outside-out
patch conﬁguration of the patch-clamp technique. Borosili-
cate glass capillaries with an outside diameter of 1 mm and an
inside diameter of 0.58 mm (Harvard Apparatus, Holliston,
MA, USA) were used as the basis for patch pipettes. Pipettes
were pulled using a PP-830 vertical two-stage pipette-puller
(Narishige, Tokyo, Japan). Pipette resistances after ﬁre polish-
ing and ﬁlling with pipette solution were 3–5 MW. Pipettes
were mounted either on a CV203BU or CV-4 head-stage
(Molecular Devices, Sunnyvale, CA, USA) connected to a
three-way coarse manipulator and micro-manipulator
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toyo, Japan). Electrodes comprised silver wires coated with
chloride ions. Electrical signals were ampliﬁed and recorded
using an Axopatch 200B or 1D ampliﬁer and pCLAMP 8
software (Molecular Devices). Data were ﬁltered at 1 kHz and
sampled digitally at 2 kHz via a Digidata 1322A analogue to
digital converter (Molecular Devices). Series resistances were
<10 MW. The voltage protocol consisted of a step from a
holding potential of 0 mV to -100 mV, followed by a 0.1 s
ramp to +100 mV, before returning to 0 mV (repeated every
10 s). Analysis was performed ofﬂine using Clampﬁt 8.2
(Molecular Devices) and Origin 7.5 software (OriginLab,
Northampton, MA, USA). The extracellular solution was SBS.
The patch-pipette solution contained (in mM): CsCl 145,
MgCl2 2, EGTA 1, HEPES 10, Na2ATP 5 and Na2GTP 0.1. The
pH was titrated to 7.2 using 4 M CsOH, and the osmolality
was 295 mOsm·kg
-1. The solution was ﬁltered using a 0.2 mm
membrane ﬁlter (Minisart, Sartorius Stedim Biotech, Goettin-
gen, Germany), divided into aliquots of ~50 mL and stored at
-20°C. Capacitance measurements in the whole-cell conﬁgu-
ration before patch excision (18.2  1.5 pF, n = 10) and then
after patch excision (1.15  0.13 pF, n = 10) conﬁrmed the
successful generation of outside-out patches, in addition to
visual inspection using the microscope; pipette capacitance
was not compensated.
Data analysis
Origin 7.5 software (OriginLab) was used for data analysis and
presentation. Averaged data are expressed as mean  SEmean.
Control and test data were produced in pairs and compared
using an independent Student’s t-test (intracellular Ca
2+ mea-
surement) or paired Student’s t-test (electrophysiology per-
formed on the same cell). Probability (P) of less than 0.05 was
considered statistically signiﬁcant. Where indicated as %, test
data were normalized to control (Ctrl) data. All intracellular
Ca
2+ measurement data are presented as n/N, where n is the
number of independent experiments (i.e. on different 96-well
plates) and N is the number of wells used in the 96-well
plates. For patch-clamp recordings, n is the number of cells
from which measurements were made.
Materials
Steroids were purchased from Sigma or Steraloids (Newport,
RI, USA), and stock solutions were stored according to the
suppliers’ instructions. The following steroids were prepared
as 10–100 mM stocks in 100% DMSO: pregnenolone
sulphate, progesterone, dehydroepiandrosterone sulphate,
pregnanolone sulphate, pregnanolone and allopregn-
anolone (3a-hydroxy-5a-pregnan-20-one or 3a,5a-
tetrahydroprogesterone). Gadolinium was purchased from
Sigma and prepared as 20–100 mM stock solutions in deion-
ized water. Dihydrotestosterone, 17b-oestradiol and cortisol
were prepared as 10 mM stocks in 100% ethanol.
Sphingosine-1-phosphate (S1P) was from Sigma, and pre-
pared as a 10 mM stock in 100% methanol. 1-palmitoyl-2-
glutaroyl-phosphatidylcholine (PGPC) was purchased as a
16.4 mM stock (in ethanol) from Cayman Chemicals (Ann
Arbor, MI, USA). All other reagents were from Sigma.
Results
Pregnenolone sulphate inhibits TRPC5
channel activity
TRPC5 channels are Ca
2+-permeable, allowing their functions
to be detected using an intracellular Ca
2+-indicator dye. Gado-
linium ions (Gd
3+) stimulated the channels and gave robust
Ca
2+-entry signals in cells expressing TRPC5 channels (Tet+),
but not cells lacking these channels (Tet-) (Figure 1A). Treat-
ment for 15 min with pregnenolone sulphate (Figure 1B)
caused concentration-dependent inhibition of Gd
3+-evoked
TRPC5 channel activity (Figure 1C,D). The threshold concen-
tration for effect was about 1 mM, and the IC50 was 19 mM
(Figure 1D). Pregnenolone sulphate also inhibited TRPC5
channel function when assessed by whole-cell voltage-clamp
recording (Figure 1E). The TRPC5 current–voltage relation-
ship (I-V) showed inward rectiﬁcation at negative voltages
and outward rectiﬁcation at positive voltages with a plateau
around 0 mV, which gave an approximate inverted S-shape.
This signature I-V was strongly suppressed, conﬁrming that
the steroid inhibited TRPC5 channels rather than back-
ground channel activity (Figure 1F, Figure S1A,B). Effects on
TRPC5 channel-mediated currents were apparent at >1 mM
pregnenolone sulphate (Figure 1G).
Inhibition by pregnenolone sulphate was not restricted to
Gd
3+-stimulated TRPC5. Alternative TRPC5 channel stimula-
tors are sphingosine-1-phosphate (S1P), which acts via
endogenous Gi/o-coupled receptors (Xu et al., 2006), and lyso-
phosphatidylcholine (LPC), which acts relatively directly
(Flemming et al., 2006). Pregnenolone sulphate signiﬁcantly
inhibited S1P- and LPC-evoked TRPC5 channel activity
(Figure 2A–D). Pregnenolone sulphate was not acting non-
speciﬁcally to inhibit Ca
2+-signalling because it did not affect
Ca
2+ signals due to TRPM2 channels (Figure 2E,F) or endog-
enous ATP-evoked Ca
2+-release (Figure 2G,H). The data
suggest that pregnenolone sulphate is a negative modulator
of TRPC5 channels.
Chemical structure-activity relationships
Pregnenolone, the non-sulphated form of pregnenolone sul-
phate (Figure 3A), did not affect TRPC5-dependent Ca
2+ entry
(Figure 3B) or ionic current (Figure 3C,D) at 10 mM concen-
tration. Pregnanolone sulphate is the same as pregnenolone
sulphate, except it lacks the double bond of ring B, and the
sulphate is in the mirrored (a) conﬁguration (Figure 3E). It
inhibited TRPC5 channel activity in Ca
2+ measurement
(Figure 3F) and patch-clamp (Figure S1C) experiments (I-Vs
are shown in Figure S1 D). Pregnanolone contains the acetyl
group at ring D, but lacks the sulphate group on ring A or the
double bond of ring B (Figure 3I). It was an inhibitor of
TRPC5 (Figure 3J,K) (I-Vs are shown in Figure S1D). The
stereo isomer of pregnanolone, allopregnanolone (Figure 3I),
lacked effect on TRPC5 channels (Figure 3J). Dehydroepi-
androsterone sulphate contains the double bond of ring B
and the b-sulphate, but the acetyl group of ring D is replaced
by a ketone (Figure 3L). In contrast to pregnenolone sulphate,
it was a poor inhibitor of TRPC5, even at 50 mM (Figure 3M).
The data suggest a stereo-selective steroid binding site that is
negatively coupled to TRPC5 channel activity.
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An important endogenous steroid that meets the
structural requirements outlined above is progesterone
(Figure 4A). Progesterone inhibited Gd
3+-stimulated TRPC5
channel activity in Ca
2+-measurement (Figure 4B) and
patch-clamp (Figure 4C–E) experiments, with marked effects
at 10 mM (Figure 4B–E) and an IC50 of 5 mM (Figure 4B).
Progesterone also inhibited S1P- and LPC-evoked TRPC5
channel activity (Figure 5A–D). The effect on responses to
S1P was particularly marked, and so we investigated
much lower concentrations of progesterone. Inhibitory
effects of 10 and 100 nM progesterone were observed
(Figure 5E,F). Such potent inhibition was not, however,
observed against ATP-evoked TRPC5 channel activity
(Figure 5G–J), suggesting that it is not a general phenom-
enon for all types of receptor-activated TRPC5 channels.
The data suggest that progesterone is a relatively potent
inhibitor of TRPC5 channels, particularly when stimulated
by S1P.
Effects of other sex steroids
Because of the effects of progesterone on TRPC5 channels,
other primary sex steroids (dihydrotestosterone and 17b-
oestradiol) were investigated, using cortisol as a comparison
(Figure 6A). In Ca
2+-measurement experiments on TRPC5-
expressing cells, 10 mM dihydrotestosterone and 17b-
oestradiol inhibited Gd
3+ responses by about 30 and 15%,
respectively, whereas cortisol had no effect (Figure 6B). The
result was similar in whole-cell patch-clamp recordings except
theeffectofdihydrotestosteronewasmorestriking,andeffects
of 17b-oestradiol were not reliably detected (Figure 6C,D). The
data suggest that inhibition of TRPC5 channels by progester-
one was mimicked by dihydrotestosterone.
Figure 1
Inhibition of Gd3+-stimulated TRPC5 channels by pregnenolone sulphate (PregS). All data were generated from cells over-expressing TRPC5 (Tet+)
except for the control (Tet-) data shown in panel A, and by intracellular Ca2+ measurement (A,C,D) or whole-cell patch-clamp (E–G). A. Effect of
application of 20 mMG d
3+. (B) Chemical structure of pregnenolone sulphate, including labelling of rings and carbon atom positions. (C) Effect
of a 15 min treatment with 10 or 50 mM pregnenolone sulphate on responses to 20 mMG d
3+ (N = 4 for each concentration). (D) Concentration-
dependent inhibition by pregnenolone sulphate (n/N = 3/12) with a ﬁtted Hill equation (IC50 19 mM). Responses to Gd
3+ were measured 80 s after
its application, as indicated in panel C. (E) Time-series plot showing the effect of extracellular application of 1 or 10 mM pregnenolone sulphate
on the outward (+95 mV) and inward currents (-95 mV) stimulated by 20 mMG d 3+. (F) Typical current-voltage relationships (I-Vs) in the presence
of Gd
3+ alone (20 Gd
3+), and then plus 100 mM pregnenolone sulphate. (G) Mean data for effects of pregnenolone sulphate (mM) on outward and
inward currents elicited by 20 mMG d 3+ (n = 3–4 for each concentration). TRPC5, transient receptor potential canonical 5.
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membrane patches
In order to investigate if sex steroids were acting relatively
directly on TRPC5 channels, we performed excised outside-
out patch recordings and bath-applied the steroids; that is
to the outer membrane surface. Gd
3+ was used to activate
the TRPC5 channels, avoiding complications of receptor-
coupling mechanisms (Figure 7A). Quite large macroscopic
ionic currents were evoked by Gd
3+, which consistently had
similar but less rectifying I-Vs compared with whole-cell cur-
rents (Figure 7B,C). Within 100 s of steroid application, the
TRPC5 channel currents were strongly suppressed by 10 mM
dihydrotestosterone or progesterone (Figure 7A–D). Full
recovery of currents was observed on wash-out of the ste-
roids. The data suggest that these sex steroids are direct and
reversible negative modulators of TRPC5 channel activity at
the membrane.
Inhibition of endogenous TRPC
channel activity
The above data on TRPC5 were generated from HEK 293 cells
that conditionally over-expressed human TRPC5 channels.
To investigate the relevance to endogenous TRPC5 channels,
we measured a Ca
2+-inﬂux signal evoked by an oxidized phos-
pholipid (PGPC), which we have previously shown is
mediated by channels containing TRPC5 and TRPC1 subunits
(Al-Shawaf et al., 2010). Progesterone (50 mM) inhibited the
PGPC-evoked Ca
2+-entry events (Figure 8A,B), consistent with
inhibition of the TRPC channels occurring. Simultaneously,
there was lowering of the basal Ca
2+ concentration by proges-
terone (Figure 8C), which was probably not related to
TRPC1/5 channels because they lack basal activity in these
cells (Al-Shawaf et al., 2010). The data suggested that endog-
enous TRPC5-containing channels were sensitive to inhibi-
tion by progesterone.
Figure 2
General inhibition of TRPC5 channels and selectivity. Data were generated by intracellular Ca
2+ measurement from TRPC5-expressing (Tet+) cells
(A–D), TRPM2-expressing (Tet+) cells (E,F), or control cells not induced to express TRPC5 channels (Tet-) (G,H). (A) Typical effect of 10 mM
pregnenolone sulphate on TRPC5 channels stimulated by 5 mM sphingosine-1-phosphate (S1P). (B) Mean data for experiments shown in panel
A( n/N = 3/18). (C) Typical effect of 10 mM pregnenolone sulphate on TRPC5 stimulated by 5 mM lysophosphatidylcholine (LPC). (D) Mean data
for experiments in panel C (n/N = 3/18). (E) Typical effect of 10 mM pregnenolone sulphate on TRPM2 stimulated by 1 mM hydrogen peroxide
(H2O2). (F) Mean data for experiments in panel E (n/N = 3/24). (G) Typical effect of 10 mM pregnenolone sulphate on Ca
2+ release elicited by
100 mM ATP. (H) Mean data for experiments in (G) (n/N = 3/12). Ctrl indicates the solvent control. TRPC5, transient receptor potential canonical
5; TRPM, transient receptor potential melastatin.
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The results of this study suggest that TRPC5 channels are
negatively modulated by certain neuroactive steroids acting
via a rapid non-genomic mechanism. The channels were
inhibited by pregnenolone sulphate, pregnanolone (or its
b-sulphated form), progesterone or dihydrotestosterone.
There was slight inhibition by 17b-oestradiol, but no effect of
pregnenolone, allopregnanolone or cortisol. Progesterone
was the strongest inhibitor, and, like dihydrotestosterone,
had a rapid and reversible effect in excised membrane
patches, suggesting the possibility of direct steroid binding to
Figure 3
Steroid structure-activity relationships at TRPC5 channels. All data were generated from cells over-expressing TRPC5 channels (Tet+)b y
intracellular Ca
2+ measurement (B,F,J,M) or whole-cell patch-clamp. (A,E,I,L) 2-dimensional structures of pregnenolone (preg), pregnanolone
sulphate (pregnas), pregnanolone (3a5b), allopregnanolone (3a5a) and dehydroepiandrosterone sulphate (DHEAS). (B) Mean data for the effect
of 10 mM pregnenolone on TRPC5 channels stimulated by 20 mMG d 3+ (n/N = 3/12). (C) Time-series plot showing the effect of 10 mM
pregnenolone on current elicited by 20 mMG d
3+. (D) Mean data for experiments in panel C (n = 3). (F) Mean data for the effect of 10 or 50 mM
pregnanolone sulphate on TRPC5 channels stimulated by 20 mMG d
3+ (n/N = 3/12). (G) Time-series plot from a whole-cell recording showing the
effect of 100 mM pregnanolone sulphate on the current elicited by 20 mMG d 3+. (H) Mean data for experiments in panel G (n = 3). (J) Mean data
for the effect of 10 mM pregnanolone or allopregnanolone on TRPC5 channels stimulated by 20 mMG d
3+ (n/N = 3/12). (K) Mean data for the effect
of 10 mM pregnanolone on current elicited by 20 mMG d 3+ (n = 3). (M) Mean data for the effect of 50 mM dehydroepiandrosterone sulphate on
TRPC5 channels stimulated by 20 mMG d
3+ (n/N = 3/24). Ctrl indicates the solvent control. TRPC5, transient receptor potential canonical 5; TRPM,
transient receptor potential melastatin.
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isomer, allopregnanolone, indicate a requirement for a spe-
ciﬁc binding site. Progesterone also inhibited endogenous
channels that contain TRPC5. The data strengthen the con-
nection between steroids and TRP channels, suggesting
unique sensing capabilities for speciﬁc steroidal moieties.
The TRP channels that have been linked to neuroactive
steroids are TRPV1 (Chen and Wu, 2004) and TRPM3
(Wagner et al., 2008; Majeed et al., 2010). In the case of
TRPV1, stimulatory and inhibitory effects occur, whereas for
TRPM3, all reported effects are stimulatory. In contrast, none
of the steroids stimulated TRPC5; only inhibitory effects
were observed. Differences are also evident in the speciﬁc
steroids that have effects: Progesterone has strong effects on
TRPC5, but no effect on TRPV1 (even at 100 mM progester-
one) and fails to stimulate TRPM3 (Wagner et al., 2008;
Majeed et al., 2010) or affect TRPM2 (data not shown); and
pregnanolone sulphate has a strong effect on TRPC5, but
only a weak effect on TRPM3. Differences are also found
when making comparisons with other types of steroid-
regulated ion channels: Notably, there is absence of effect of
allopregnanolone on TRPC5 that contrasts markedly with
GABAA ligand-gated ion channels, which are potently poten-
tiated by this steroid (Schumacher et al., 2007). Overall, the
ﬁndings suggest that steroid binding sites exist on TRP chan-
nels, as they do on other ion channel types, such as GABAA
receptors. Analysis of the steroid structure-activity relation-
ships for GABAA receptors has been extensive (Veleiro and
Burton, 2009), whereas comparable information for TRP
channels is limited. Nevertheless, there are indications that
the steroid sites on, or near, TRP channels are different
between classes of TRP channel and different compared with
other types of ion channel, allowing responses to different
steroids. Notably, small changes in steroid chemistry, includ-
ing stereo-isomerism, make the difference between effect
and no effect. Inspection of 3D structures of steroids that are
active against TRPC5 compared with allopregnanolone,
which is inactive, suggests that subtle changes in rings A and
B are critical in determining modulation of TRPC5 channels
(Figure S2).
Figure 4
Inhibition of Gd
3+-stimulated TRPC5 channels by progesterone. All data were generated from cells over-expressing TRPC5 channels (Tet+)b y
intracellular Ca2+ measurement (B,C) or whole-cell patch-clamp. (A) Two-dimensional structure of progesterone. (B) Mean data for the inhibitory
effect of progesterone on TRPC5 channel-mediated Ca2+ signals elicited by 20 mMG d 3+, ﬁtted using the Hill equation giving an IC50 of 5 mM
(n/N = 6/30 for 1 mM, and 3/12 each for 10 and 50 mM progesterone). (C) Typical time-series plot showing the effects of application of 1 and
10 mM progesterone on current elicited by 20 mMG d
3+. (D) Typical I-Vs in the presence of Gd
3+ alone (20 Gd
3+), and then plus 1 and 10 mM
progesterone. (E) Mean data for experiments in (C,D) (n = 13 and 7 for 1 and 10 mM progesterone, respectively). TRPC5, transient receptor
potential canonical 5.
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in onset and occurred in excised membrane patches, which
means that it is independent of the channel expression
mechanism or intracellular organelles, and argues for a
membrane-delimited effect. While it is tempting to conclude
that the steroids bind directly to TRPC5, there are other
possibilities to consider: Relatively high concentrations of
steroids could modify the structure of the bilayer, and thus
indirectly modulate protein function; however, this is
unlikely to be relevant to action on TRPC5 channels because
of the observed structure–activity relationships, including an
effect of pregnanolone but not allopregnanolone. We also
found no effect on other membrane events, including TRPM2
activity and ATP receptor-coupling to Ca
2+-release. G protein-
Figure 5
General TRPC5 channel inhibition by progesterone and potency against S1P-evoked activity. Data were generated by intracellular Ca
2+ measure-
ment from TRPC5-expressing (Tet+) cells or cells not induced to express TRPC5 channels (Tet-) (H,J). (A) Experimental record showing the effect
of 10 mM progesterone on TRPC5 channels stimulated by 5 mM sphingosine-1-phosphate (S1P). (B) Mean data for experiments in panel A
(n/N = 3/18). (C) Typical trace showing the effect of 10 mM progesterone on TRPC5 channels stimulated by 5 mM lysophosphatidylcholine (LPC).
(D) Mean data for experiments in panel C (n/N = 3/18). (E) Typical trace showing the effects of 0.01 and 0.1 mM progesterone (prog) on TRPC5
channels stimulated by 5 mM S1P. (F) Mean data for experiments in panel E (n/N = 4/18). (G,H) Typical traces showing the effect of 0.1 mM
progesterone (prog) on Ca
2+ signals elicited by 100 mM ATP in cells. Note the more sustained response in Tet+ cells, reﬂecting TRPC5 channel
activity. (I,J) Mean data for the effect of 0.1 mM progesterone (+prog) on the transient (Trans.) and sustained (Sust.) responses evoked by ATP in
TRPC5 channel-expressing or control (Tet-) cells (n/N = 3/16). Ctrl indicates the solvent control. S1P, sphingosine-1-phosphate. TRPC5, transient
receptor potential canonical 5.
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Gi/o proteins (Schumacher et al., 2007), and TRPC5 channels
are well recognized to be modulated by agonists at G protein-
coupled receptors; however, the TRPC5 channel is stimulated
by such agonists, including when acting through a Gi/o
pathway (Xu et al., 2006; Beech, 2007), thus contrasting with
the universal inhibitory actions of the steroids, including
progesterone presented here. Progesterone also binds to the
progesterone receptor membrane component-1, a protein
with a relatively low afﬁnity for progesterone, and this inter-
action accounts for some membrane-initiated effects of
progesterone (Peluso, 2007). However, we are not aware of
any evidence that this protein can couple to ion channel
function.
The physiological relevance of neuroactive steroid effects
on TRPC5 is currently uncertain. Endogenous concentrations
of serum or brain pregnenolone sulphate in humans almost
certainly do not become high enough to affect these channels
(Schumacher et al., 2008), although we cannot exclude that
local concentrations may be higher and regulated by local
enzyme systems. Greater concentrations may be achieved, for
example through oral administration of pregnenolone or
DHEA as a dietary supplement, but this is considered to be
pharmacology (Johnson et al., 2002). Progesterone was more
potent, but was not a general inhibitor of all types of TRPC5
channel activity at concentrations of progesterone detected
during the menstrual cycle (Havlikova et al., 2006). In preg-
nancy, however, sufﬁcient progesterone may circulate to
affect all modes of TRPC5 channel activity (Frye, 2007). More
potent and potentially physiologically relevant actions of
progesterone were observed, but they were restricted to S1P-
evoked TRPC5 channel activity. Whether these more potent
effects are relevant to other types of receptor-activated TRPC5
channel is unknown, but we did not reproduce them for
ATP-evoked activity. It is possible that they could be
explained by effects of progesterone on the S1P receptor or its
Gi/o signalling pathway that couples to TRPC5 channels (Xu
et al., 2006).
Figure 6
Inhibition of TRPC5 channels by dihydrotestosterone. (A) Chemical structures of dihydrotestosterone (DhT), 17b-oestradiol (17b) and cortisol
(cort). (B–D) Data were generated by intracellular Ca
2+ measurement (B) or whole-cell patch-clamp (C,D) from TRPC5-expressing (Tet+) cells B.
Mean data for the effect of 15 min treatment with 10 mM each of dihydrotestosterone, 17b-oestradiol or cortisol on TRPC5 channels stimulated
by 20 mMG d
3+ (n/N = 3/24). (C) Typical time-series plot showing the effect of extra-cellular application of 10 mM cortisol, dihydrotestosterone
or 17b-oestradiol on currents at -95 mV and +95 mV elicited by 20 mMG d
3+. The durations of compound application are indicated by horizontal
bars. (D) Mean normalized data for experiments in panel C (n = 4–5 for each steroid, each compared with its own control). TRPC5, transient
receptor potential canonical 5.
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Inhibition of TRPC5 channels in excised outside-out patches. Data were generated from patches excised from cells over-expressing TRPC5 channels
(Tet+). (A) Typical time-series plot from an outside-out patch recording showing the effects of extra-cellular application of 10 mM dihydrotest-
osterone (DhT) or progesterone (prog) on current elicited by 20 mMG d
3+. Arrows indicate the time points (i–iv) at which I-Vs were sampled for
panels B and C. (B,C) Typical I-Vs in the presence of Gd
3+ alone (20 Gd3+), and then plus 10 mM dihydrotestosterone (B) and progesterone (C).
(D) Mean data for experiments in (A–C) (n = 4–6). TRPC5, transient receptor potential canonical 5.
Figure 8
Inhibition by progesterone of Ca
2+-entry through endogenous TRPC5-containing channels. Data were generated by intracellular Ca
2+ measure-
ment from human saphenous vein vascular smooth muscle cells (VSMC). (A) Effect of 15 min treatment with 50 mM progesterone (prog) on the
Ca
2+ response elicited by 3 mM 1-palmitoyl-2-glutaroyl-phosphatidylcholine (PGPC). (B,C) Mean data for the effects of progesterone on the
amplitude of the PGPC response (B, normalized to control) and basal Ca
2+ level (C, absolute fura-2 ratio) in VSMC (n/N = 5/54). TRPC5, transient
receptor potential canonical 5.
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modulated by neuroactive steroids, adding to data published
previously on TRPV (TRPV1) and TRPM (TRPM3) channels. It
is the ﬁrst report of an effect of the important hormone,
progesterone, on TRP channels. The physiological signiﬁ-
cance of the steroid effects on TRPC5 has yet to be revealed
but there is, for example potential relevance to anxiety states
(Toufexis et al., 2004; Schumacher et al., 2007; Auger and
Forbes-Lorman, 2008), growth cone formation and neuropro-
tection (Davare et al., 2009), and vascular remodelling in
response to oxidized phospholipids (Al-Shawaf et al., 2010).
Our study strengthens the association between steroids and
TRP channels and suggests that the channels are non-
genomic steroid sensors that enable membrane-initiated
events.
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